Tomoya Hamaguchi

1.0k total citations
47 papers, 761 citations indexed

About

Tomoya Hamaguchi is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Tomoya Hamaguchi has authored 47 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Molecular Biology and 18 papers in Surgery. Recurrent topics in Tomoya Hamaguchi's work include Diabetes Management and Research (18 papers), Pancreatic function and diabetes (18 papers) and Metabolism, Diabetes, and Cancer (17 papers). Tomoya Hamaguchi is often cited by papers focused on Diabetes Management and Research (18 papers), Pancreatic function and diabetes (18 papers) and Metabolism, Diabetes, and Cancer (17 papers). Tomoya Hamaguchi collaborates with scholars based in Japan, Australia and Somalia. Tomoya Hamaguchi's co-authors include Mitsuyoshi Namba, Tomoyuki Yamasaki, Hiromu Nakajima, Jun‐ichiro Miyagawa, Tomoyuki Katsuno, Masayuki Miuchi, Nina Raben, Norio Kôno, Seiichiro Tarui and Yoshiki Kusunoki and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Biochemical Journal.

In The Last Decade

Tomoya Hamaguchi

47 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoya Hamaguchi Japan 18 326 266 243 148 108 47 761
Masayuki Noritake Japan 16 132 0.4× 243 0.9× 127 0.5× 73 0.5× 120 1.1× 30 730
Won Gu Jang South Korea 9 173 0.5× 524 2.0× 181 0.7× 44 0.3× 135 1.3× 12 810
Miriam Lee‐Rueckert Finland 22 204 0.6× 315 1.2× 420 1.7× 31 0.2× 83 0.8× 42 996
A. Bhala United States 11 335 1.0× 509 1.9× 47 0.2× 79 0.5× 190 1.8× 14 898
Egbert Schulze Germany 20 361 1.1× 510 1.9× 157 0.6× 133 0.9× 56 0.5× 36 1.0k
Jiwon Song United States 11 195 0.6× 346 1.3× 372 1.5× 182 1.2× 68 0.6× 20 862
C. Plas France 14 215 0.7× 243 0.9× 261 1.1× 28 0.2× 85 0.8× 38 596
Iwona Wybrańska Poland 15 88 0.3× 327 1.2× 102 0.4× 81 0.5× 190 1.8× 44 739
L.M. Havekes Netherlands 13 198 0.6× 136 0.5× 235 1.0× 115 0.8× 69 0.6× 26 610
Yoshiro Kitahara Japan 12 152 0.5× 164 0.6× 102 0.4× 38 0.3× 116 1.1× 19 537

Countries citing papers authored by Tomoya Hamaguchi

Since Specialization
Citations

This map shows the geographic impact of Tomoya Hamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Hamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Hamaguchi more than expected).

Fields of papers citing papers by Tomoya Hamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Hamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Hamaguchi. The network helps show where Tomoya Hamaguchi may publish in the future.

Co-authorship network of co-authors of Tomoya Hamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Hamaguchi. A scholar is included among the top collaborators of Tomoya Hamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Hamaguchi. Tomoya Hamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozawa, Junji, Megu Y. Baden, Yoshiya Hosokawa, et al.. (2023). Effects of liraglutide on intrapancreatic fat deposition in patients with type 2 diabetes. Clinical Nutrition ESPEN. 59. 208–213. 5 indexed citations
2.
Kusunoki, Yoshiki, Tomoyuki Katsuno, Takafumi Akagami, et al.. (2014). Medium-Term Effects of Insulin Degludec on Patients with Type 1 Diabetes Mellitus. Drugs in R&D. 14(2). 133–138. 7 indexed citations
3.
Konya, Hiroyuki, et al.. (2013). Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. SHILAP Revista de lepidopterología. 2 indexed citations
4.
Konya, Hiroyuki, Tomoyuki Katsuno, Masayuki Miuchi, et al.. (2013). Effects of combination therapy with mitiglinide and voglibose on postprandial plasma glucose in patients with type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. 6. 317–317. 13 indexed citations
5.
Maeda, Aya, Jun‐ichiro Miyagawa, Masayuki Miuchi, et al.. (2013). Effects of the naturally‐occurring disaccharides, palatinose and sucrose, on incretin secretion in healthy non‐obese subjects. Journal of Diabetes Investigation. 4(3). 281–286. 38 indexed citations
6.
Hamaguchi, Tomoya, Masafumi Koga, Jun Murai, et al.. (2011). Estimation of HbA1c response to sitagliptin by change in glycated albumin level for 2 weeks. Journal of Diabetes Investigation. 3(2). 175–178. 10 indexed citations
7.
Katsuno, Tomoyuki, Jun‐ichiro Miyagawa, Masayuki Miuchi, et al.. (2011). Incretin responses to oral glucose load in Japanese non-obese healthy subjects. Diabetes Therapy. 2(1). 20–28. 6 indexed citations
8.
Katsuno, Tomoyuki, Tomoya Hamaguchi, J Miyagawa, et al.. (2010). Asymmetric dimetylarginine (ADMA) could affect on cardiovascular complications in type 2 diabetes, particularly complicated with nephropathy. Endocrine Journal. 57. 378. 1 indexed citations
9.
Zhang, Jianfa, Kazuya Yamagata, Junji Kozawa, et al.. (2007). Continuous stimulation of human glucagon-like peptide-1 (7–36) amide in a mouse model (NOD) delays onset of autoimmune type 1 diabetes. Diabetologia. 50(9). 1900–1909. 58 indexed citations
10.
Konya, Hiroyuki, Tomoya Hamaguchi, Tomoyuki Katsuno, et al.. (2006). Clinical significance of circulating hepatocyte growth factor, a new risk marker of carotid atherosclerosis in patients with Type 2 diabetes. Diabetic Medicine. 23(6). 617–622. 27 indexed citations
11.
Hamaguchi, Tomoya, Takahisa Hirose, Hideki Asakawa, et al.. (2004). Efficacy of glimepiride in type 2 diabetic patients treated with glibenclamide. Diabetes Research and Clinical Practice. 66. S129–S132. 33 indexed citations
12.
Nakajima, Hiromu, Nina Raben, Tomoya Hamaguchi, & Tomoyuki Yamasaki. (2002). Phosphofructokinase Deficiency Past, Present and Future. Current Molecular Medicine. 2(2). 197–212. 61 indexed citations
13.
Yoshiuchi, Issei, Kazuya Yamagata, Qin Yang, et al.. (1999). Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization. Diabetologia. 42(5). 621–626. 38 indexed citations
14.
Hamaguchi, Tomoya, et al.. (1995). Phosphofructokinase deficiency: Recent advances in molecular biology. Muscle & Nerve. 18(S14). S28–S34. 15 indexed citations
15.
Nakajima, Hideaki, T Noguchi, Kayo Imamura, et al.. (1995). Compound Heterozygous Mutations Affecting Both Hepatic and Erythrocyte Isozymes of Pyruvate Kinase. Biochemical and Biophysical Research Communications. 208(3). 991–998. 21 indexed citations
16.
Mineo, Ikuo, Misako Kaido, Harutoshi Fujimura, et al.. (1995). A new variant case of muscle phosphofructokinase deficiency, coexisting with gastric ulcer, gouty arthritis, and increased hemolysis. Muscle & Nerve. 18(S14). S39–S44. 4 indexed citations
17.
Hotta, Kikuko, Hiromu Nakajima, Tomoyuki Yamasaki, et al.. (1991). Rat‐liver‐type phosphofructokinase mRNA. European Journal of Biochemistry. 202(2). 293–298. 28 indexed citations
18.
Mineo, Ikuo, Norio Kôno, Yuya Yamada, et al.. (1990). Glucose infusion abolishes the excessive ATP degradation in working muscles of a patient with McArdle's disease. Muscle & Nerve. 13(7). 618–620. 13 indexed citations
19.
Kiyokawa, Hiroaki, Norio Kôno, Tomoya Hamaguchi, et al.. (1989). Hyperinsulinemia due to Impaired Insulin Clearance Associated with Fasting Hypoglycemia and Postprandial Hyperglycemia: An Analysis of a Patient with Antiinsulin Receptor Antibodies*. The Journal of Clinical Endocrinology & Metabolism. 69(3). 616–621. 12 indexed citations
20.
Ishikawa, Hiroki, et al.. (1982). Effects of dipyridamole on proteinuria in chronic glomerulonephritis and the nephrotic syndrome.. PubMed. 32(3). 301–9. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Noritake Breakdown of academic impact, for papers by Won Gu Jang Breakdown of academic impact, for papers by Miriam Lee‐Rueckert Breakdown of academic impact, for papers by A. Bhala Breakdown of academic impact, for papers by Egbert Schulze Breakdown of academic impact, for papers by Jiwon Song Breakdown of academic impact, for papers by C. Plas Breakdown of academic impact, for papers by Iwona Wybrańska Breakdown of academic impact, for papers by L.M. Havekes Breakdown of academic impact, for papers by Yoshiro Kitahara
Rankless by CCL
2026